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This paper describes the role of ␣-subunit VISIT-DG sequence residues ␣Ser-347 and ␣Gly-351 in catalytic sites of
Escherichia coli F1Fo ATP synthase. X-ray structures show the
very highly conserved ␣-subunit VISIT-DG sequence in close
proximity to the conserved phosphate-binding residues ␣Arg376, ␤Arg-182, ␤Lys-155, and ␤Arg-246 in the phosphate-binding subdomain. Mutations ␣S347Q and ␣G351Q caused loss of
oxidative phosphorylation and reduced ATPase activity of
F1Fo in membranes by 100- and 150-fold, respectively, whereas
␣S347A mutation showed only a 13-fold loss of activity and also
retained some oxidative phosphorylation activity. The ATPase
of ␣S347Q mutant was not inhibited, and the ␣S347A mutant
was slightly inhibited by MgADP-azide, MgADP-fluoroaluminate, or MgADP-fluoroscandium, in contrast to wild type
and ␣G351Q mutant. Whereas 7-chloro-4-nitrobenzo-2-oxa-1,
3-diazole (NBD-Cl) inhibited wild type and ␣G351Q mutant
ATPase essentially completely, ATPase in ␣S347A or ␣S347Q
mutant was inhibited maximally by ⬃80 –90%, although reaction
still occurred at residue ␤Tyr-297, proximal to the ␣-subunit
VISIT-DG sequence, near the phosphate-binding pocket. Inhibition characteristics supported the conclusion that NBD-Cl reacts
in ␤E (empty) catalytic sites, as shown previously by x-ray structure
analysis. Phosphate protected against NBD-Cl inhibition in wild
type and ␣G351Q mutant but not in ␣S347Q or ␣S347A mutant.
The results demonstrate that ␣Ser-347 is an additional residue
involved in phosphate-binding and transition state stabilization in
ATP synthase catalytic sites. In contrast, ␣Gly-351, although
strongly conserved and clearly important for function, appears not
to play a direct role.

F1Fo-ATP synthase is the enzyme responsible for ATP synthesis by oxidative or photophosphorylation in membranes of
bacteria, mitochondria, and chloroplasts. It is the fundamental
means of cell energy production in animals, plants, and almost
all microorganisms. It works like a nanomotor and is structurally similar in all species. In its simplest form, as in Escherichia
coli, it contains eight different subunits distributed in the
water-soluble F1 sector (subunits ␣3␤3␥␦⑀) and the membraneassociated Fo sector (subunits ab2c10). The total molecular size
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is ⬃530 kDa. In chloroplasts there are two isoforms of subunit
b. In mitochondria, there are 7–9 additional subunits, depending on the source, but in toto they contribute only a small fraction of additional mass and may have regulatory roles (1– 4).
ATP hydrolysis and synthesis occur in the F1 sector. X-ray
structures of bovine enzyme (5) established the presence of three
catalytic sites at ␣/␤ subunit interfaces of the ␣3␤3 hexamer. Proton transport occurs through the membrane-embedded Fo. The
␥-subunit contains three ␣-helices. Two of these helices form a
coiled coil and are located in the central space of the ␣3␤3 hexamer.
Proton gradient-driven clockwise rotation of ␥ (as viewed from the
membrane) leads to ATP synthesis and anticlockwise rotation of ␥
results from ATP hydrolysis. In recent terminology, the rotor consists of ␥⑀cn, and the stator consists of b2␦ (6, 7). The function of the
stator is to prevent co-rotation of catalytic sites with the rotor.
Detailed reviews of ATP synthase structure and function may be
found in Refs. 8 –13.
To better understand the reaction mechanism of ATP synthesis and hydrolysis and their relationship to mechanical rotation in this biological nanomotor, we have focused our efforts
on determining the role of conserved residues in and around
catalytic site Pi-binding subdomain. Knowledge of Pi-binding
residues and residues surrounding the Pi-binding subdomain is
imperative for accomplishing (i) the molecular modulation of
the catalytic site for the improved catalytic and motor function
of this enzyme, (ii) an explanation of how ATP synthase binds
ADP and Pi within its catalytic sites in the face of a relatively
high ATP/ADP concentration ratio, and (iii) understanding the
relationship between Pi binding and subunit rotation (14 –16).
Earlier attempts to measure Pi binding in purified E. coli F1
using [32P]Pi (15) or by competition with ATP or AMP-PNP2 in
fluorescence assays of nucleotide binding (18, 19) failed to
detect appreciable Pi binding at physiological Pi concentration.
So, we turned to the assay devised by Perez et al. (20) in which
the protection afforded by Pi against inhibition of ATPase activity induced by covalent reaction with 7-chloro-4-nitrobenzo-2oxa-1, 3,-diazole (NBD-Cl) provides the measure of Pi binding.
Earlier Orriss et al. (21) showed by x-ray crystallography that
the covalent adduct formed by NBD-Cl is specifically in the ␤E
catalytic site (Fig. 1A); thus protection afforded by Pi indicates
that binding of Pi occurs at the ␤E catalytic site. By modifying
the above assay for use with E. coli purified F1 or F1Fo mem2

The abbreviations used are: AMP-PNP, 5⬘adenylyl-␤, ␥-imidodiphosphate;
NBD-Cl, 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole; DTT, dithiothreitol; TES,
2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid;
DCCD, dicyclohexylcarbodiimide.
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This unfortunately renders the
potentially more convenient centrifuge column assay unsuitable with
the E. coli enzyme.
A mechanism of condensation of
Pi with MgADP was proposed by
Senior et al. (32). The x-ray crystallography structure of bovine ATP
synthase by Menz et al. (23) shows
the transition state analog MgADPAlF⫺
4 trapped in catalytic sites (Fig.
1B). It is clear from the geometry of
this complex that the fluoroaluminate group occupies the position of
the ATP-␥-phosphate in the predicted transition state. Similarly,
Pedersen and co-workers (33) reFIGURE 1. X-ray structures of catalytic sites in mitochondrial ATP synthase showing spatial relationship ported the first transition state-like
of ␣-subunit VISIT-DG sequence ␣S347 and ␣G351. A, reacted NBD-O-tyrosyl-297 in the ␤E site (21). B, the structure of F
using enzyme
1
␤DP site in the AlF⫺
4 -inhibited enzyme (23). E. coli residue numbering is shown. The triangle shows the residues
obtained
from
rat
liver
and crystal␤Lys-155, ␤Arg-182, ␤Arg-246, ␣Arg-376, and ␣Ser-347 forming a triangular Pi-binding site. Rasmol software
lized with the Pi analog vanadate
was used to generate these figures.
(Vi). This work further demonstrated that ADP was not essential,
suggesting that the MgVi-F1 complex inhibited the catalytic activity
to the same extent as that observed
for the MgADP-Vi-F1 complex.
Unfortunately, neither MgVi nor
MgADP-Vi inhibits the E. coli enzyme (24). Thus we have relied on
inhibition of ATPase activity by fluoroaluminate (or fluoroscandium)
to assess the potential to stabilize a
transition state complex (24 –26, 28,
30). Through mutagenesis and by
employing the NBD-Cl protection
assay as well as ATPase inhibition
FIGURE 2. Amino acid sequence alignment of evolutionarily conserved ␣-subunit VISIT-DG sequence. by transition state analogs, we can
␣-Subunit sequence from different species is aligned. The highly conserved VISIT-DG sequence is highlighted
in gray. The starting residue arginine shown here for E. coli is ␣R300. Conserved ␣Ser-347 and ␣Gly-351 are probe the direct or indirect role of
residues in Pi binding. In this manudenoted by bold font.
script, we explore the possible role
branes, we have previously investigated the relationship played by ␣Ser-347 and ␣Gly-351 residues in the highly conbetween Pi binding and catalysis for six residues, namely served ␣-subunit VISIT-DG sequence. Fig. 1B shows the loca␤Arg-246, ␤Asn-243, ␣Arg-376, ␤Lys-155, ␤Arg-182, and tion of ␣Ser-347 and ␣Gly-351 residues. Notably, ␣Ser-347
␣Phe-291.3 All of these residues are positioned in proximity to appears to occupy a strategic position in the Pi-binding subdothe phosphate analogs AlF3 or SO2⫺
4 in x-ray structures of catmain. Fig. 2 shows the evolutionarily conserved ␣-subunit
alytic sites (22, 23). We found that four residues, namely ␤Arg- VISIT-DG sequence along with surrounding residues of ␣-sub246, ␣Arg-376, ␤Lys-155, and ␤Arg-182, grouped in a triangu- unit from a variety of species. The basic questions we asked
lar fashion are directly involved in Pi binding (Fig. 1B) (24 –30). were: what role does ␣Ser-347 or ␣Gly-351 play? Do the mutaIt is interesting to note that Penefsky (31) detected [32P]Pi tions ␣S347A, ␣S347Q, or ␣G351Q have any effect on Pi bindbinding with a Kd(Pi) in the range of 0.1 mM in mitochondrial ing or transition state formation?
membranes using a pressure ultrafiltration method, and the
results are in agreement with data obtained from the NBD-Cl MATERIALS AND METHODS
protection assay (20). However, Penefsky could not detect Pi
Construction of Wild Type and Mutant Strains of E. coli—
binding in E. coli F1Fo, and thus it is evident that Pi dissociates The wild type strain was pBWU13.4/DK8 (34). Mutagenesis
more rapidly from E. coli F1 than it does from mitochondrial F1. was by the method of Vandeyar et al. (35). The template for
oligonucleotide-directed mutagenesis was M13mp18 contain3
ing the HindIII-XbaI fragment from pSN6. pSN6 is a plasmid
E. coli residue numbers are used throughout.
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containing the ␤Y331W mutation from plasmid pSWM4 (36)
introduced on a SacI-EagI fragment into pBWU13.4 (34),
which expresses all the ATP synthase genes. pSWM67/AN888
strain was used for ␣S347A mutant (37). The mutagenic oligonucleotide for ␣S347Q was CCAACGTAATCCAGATTACCGATGG, where the underlined bases introduce the mutation
and a new XcmI restriction site, and that for ␣G351Q was
CCATTACCGATCAGCAAATCTTCCTGGAAACC, where
the underlined bases introduce the mutation and a silent mutation removes BglII restriction site. DNA sequencing was performed to confirm the presence of mutations and absence of
undesired changes in sequence, and the mutations were transferred to pSN6 on a Csp451 (an isoschizomer of BstBI) and
Pml1 fragment generating the new plasmids pZA13 (␣S347Q/
␤Y331W) and pZA14 (␣G351Q/␤Y331W). Each plasmid was
transformed into strain DK8 (38) containing a deletion of ATP
synthase genes for expression of the mutant enzymes. It may be
noted that both mutant strains contained the ␤Y331W mutation, which is valuable for measurement of nucleotide binding
parameters (36) and does not affect function significantly on its
own. Although the presence of ␤Y331W mutation was not utilized in this work, the Trp mutation was included for possible
future use.
Preparation of E. coli Membranes, Measurement of Growth
Yield in Limiting Glucose Medium, and Assay of ATPase Activity of Membranes—E. coli membranes were prepared as in Ref.
39. It should be noted that this procedure involves three washes
of the initial membrane pellets. The first wash is performed in
buffer containing 50 mM TES, pH 7.0, 15% glycerol, 40 mM
6-aminohexanoic acid, 5 mM p-aminobenzamidine. The following two washes are performed in buffer containing 5 mM
TES, pH 7.0, 15% glycerol, 40 mM 6-aminohexanoic acid, 5 mM
p-aminobenzamidine, 0.5 mM DTT, 0.5 mM EDTA. Prior to the
experiments, the membranes were washed twice more by
resuspension and ultracentrifugation in 50 mM TrisSO4, pH 8.0,
2.5 mM MgSO4. Growth yield in limiting glucose was measured
as in Ref. 40. ATPase activity was measured in 1 ml of assay
buffer containing 10 mM NaATP, 4 mM MgCl2, 50 mM TrisSO4,
pH 8.5, at 37 °C. The reactions were started by the addition of
membranes and stopped by the addition of SDS to 3.3% final
concentration. Pi released was assayed as in Ref. 41. For wild
type membranes (20 –30 g of protein), reaction times were
5–10 min. For mutant membranes (40 – 60 g of protein), reaction times were 30 –50 min. All of the reactions were shown to
be linear with time and protein concentration. SDS gel electrophoresis on 10% acrylamide gels was as in Ref. 42. Immunoblotting with rabbit polyclonal anti-F1-␣ and anti-F1-␤ antibodies
was as in Ref. 43.
Inhibition of ATPase Activity by NBD-Cl and Protection by
MgADP or Pi—NBD-Cl was prepared as a stock solution in
dimethyl sulfoxide and protected from light. The membranes
(0.2– 0.5 mg/ml) were reacted with NBD-Cl for 60 min in the
dark at room temperature in 50 mM TrisSO4, pH 8.0, 2.5 mM
MgSO4, and then 50-l aliquots were transferred to 1 ml of
ATPase assay buffer to determine ATPase activity. Where protection from NBD-Cl inhibition by ADP or Pi was determined,
the membranes were preincubated 60 min with protecting
agent at room temperature before the addition of NBD-Cl.
APRIL 17, 2009 • VOLUME 284 • NUMBER 16

MgSO4 was present, equimolar with ADP or Pi. Control samples containing the ligand without added NBD-Cl were
included. Neither Pi (up to 50 mM) nor MgADP (up to 10 mM)
had any inhibitory effect alone.
Reversal of NBD-Cl Inhibited ATPase Activity by DTT—For
reversal of NBD-Cl inhibition by DTT, the membranes were
first reacted with NBD-Cl (150 M) for 1 h at room temperature, and then DTT (final ⫽ 4 mM) was added, and incubation
continued for 1 h at room temperature before ATPase assay.
Control samples without NBD-Cl and/or DTT were incubated
for the same times.
Inhibition of ATPase Activity by Azide, Fluoroaluminate, or
Fluoroscandium—Azide inhibition was measured by preincubating membranes with varied concentrations of sodium azide
for 30 min. Then 1 ml of ATPase assay buffer was added to
measure the activity. For measurements of fluoroaluminate or
fluoroscandium inhibition, the membranes were incubated for
60 min at room temperature in 50 mM TrisSO4, 2.5 mM MgSO4,
1 mM NaADP, and 10 mM NaF at a protein concentration of
0.2– 0.5 mg/ml in presence of AlCl3 or ScCl3 added at varied
concentration (see “Results”). 50-l aliquots were then added
to 1 ml of ATPase assay buffer, and activity was measured as
above. It was confirmed in control experiments that no inhibition was seen if MgSO4, NaADP, or NaF was omitted.
Inhibition of ATPase Activity by Dicyclohexylcarbodiimide
(DCCD)—Covalent modification of wild type and mutant
membrane was performed as described by Weber et al. (44).
ATPase activity was measured by adding 1 ml of ATPase assay
buffer containing 10 mM NaATP, 4 mM MgCl2, 50 mM TrisSO4,
pH 8.5, at 37 °C to the 100-l aliquots of 16 h DCCD-modified
ATP synthase.

RESULTS
Growth Properties of ␣S347Q, ␣S347A, and ␣G351Q
Mutants of E. coli ATP Synthase—Three new mutants,
␣S347Q, ␣S347A, and ␣G351Q, were generated. These two
residues were chosen for mutagenesis because of their strong
conservation in the ␣-subunit VISIT-DG sequence and their
close proximity to the Pi-binding pocket. The ␣S347A mutant
was used to appreciate the role of Ser-OH side chain in Pi binding and transition state. ␣S347Q and ␣G351Q mutants were
designed to understand the impact of larger side chain of Gln on
␣Ser-347 and ␣Gly-351.
Table 1 shows that introduction of Gln as ␣S347Q and
␣G351Q resulted in the loss of oxidative phosphorylation. Both
mutations prevented growth on succinate-containing medium,
and growth yields in limiting glucose medium were reduced
close to those of the ATP synthase null control. ␣S347A
mutant, on the other hand, resulted in partial loss of oxidative
phosphorylation. Specific ATPase activities of membrane preparations containing mutant enzymes were compared with wild
type and null control, and the values are shown in Table 1.
␣S347Q and ␣G351Q reduced the ATPase activity by 100 –
150-fold, whereas ATPase activity was reduced only 13-fold by
␣S347A. Membranes prepared from the mutants contained the
same amount of ␣ and ␤ subunits as wild type, as determined by
SDS gel electrophoresis and immunoblotting (26) (data not
shown); therefore, reduced ATPase is not due to impaired
JOURNAL OF BIOLOGICAL CHEMISTRY

10749

Role of ␣Ser-347 and ␣Gly-351 in E. coli ATP Synthase
TABLE 1
Effects of ␣ Ser-347 and ␣ Gly-351 mutation on cell growth and
ATPase activity
Mutationa

Growth on
succinateb

Growth yield in
limiting glucose

ATPase
activityc

%

mol/min/mg

Wild type
Null
␤Y331W
␣S347Q
␣S347A
␣G351Q

⫹⫹⫹⫹
⫺
⫹⫹⫹⫹
⫾
⫹
⫾

100
46
95
55
65
54

28
0
26
0.20
2.18
0.25

Wild type, pBWU13.4/DK8; Null, pUC118/DK8, ␣S347Q/DK8, ␣G351Q/DK8,
and ␣S347A/AN888. Both ␣S347Q and ␣G351Q mutants were expressed with the
␤Y331W mutation also present, which does not significantly affect growth. The
data are the means of four to six experiments each.
b
Growth on succinate plates after 3 days estimated by eye. ⫹⫹⫹⫹, heavy growth;
⫹, partial growth; ⫾, very light growth; ⫺, no growth.
c
ATPase activity was measured at 37 °C and expressed as mol of ATP hydrolyzed/
min/mg of membrane protein. Each individual experimental point is itself the
mean of duplicate assay tubes. The data are derived from two separate membrane
preparations. The results from separate membrane preparations were in excellent
agreement within ⫾10%.
a

assembly of ATP synthase or loss of F1 during membrane
preparation.
Inhibition of ATPase Activity of ATP Synthase in Membranes
by NBD-Cl and Reversal by Dithiothreitol—We previously
established that Pi binding by mutant or wild type ATP synthase
can be assayed using either membrane preparations or purified
F1, with equivalent results (24, 26). In this work we used membrane preparations that are more convenient. Fig. 3 shows
NBD-Cl inhibition of wild type and mutant membranes in the
presence of varied concentrations of NBD-Cl. In wild type
potent inhibition occurred with no residual activity, and this is
consistent with previous studies (24 –28, 30). ␣G351Q mutant
was also completely inhibited, and ␣S347Q or ␣S347A mutant
were inhibited by ⬃80 –90% with ⬃20 –10% residual activity. In
previous studies (24 –28, 30), we have noted several instances
where mutant ATP synthases were incompletely inhibited by
NBD-Cl. To be sure that maximal reaction with NBD-Cl had
been reached, we incubated each membrane preparation with
150 M NBD-Cl for 1 h as in Fig. 3, followed by an additional
pulse of 200 M NBD-Cl, continuing the incubation for an additional hour before assaying ATPase activity. Very little or no
additional inhibition occurred (Fig. 4, left panel). This shows
that the reaction of NBD-Cl was complete and that fully reacted
␣S347Q mutant membranes retained residual activity. Next,
we checked whether inactivation by NBD-Cl could be reversed
by the addition of the reducing agent DTT because reversibility
by DTT was indicative of specificity of reaction in previous
studies. Wild type and mutant enzymes were preincubated
with 150 M NBD-Cl as in Fig. 3, and then 4 mM DTT was
added, and incubation continued for 1 h before ATPase
assay. It was seen that DTT completely restored full activity
in all cases (Fig. 4, right panel). This indicates that NBD-Cl
reacts specifically with residue ␤Tyr-297 in the wild type as
well as in both mutants (45, 46).
Protection against NBD-Cl Inhibition of ATPase Activity by
MgADP or Pi—Fig. 5 shows the data for MgADP protection in
membrane enzymes, and it is seen that wild type and mutants
were protected against NBD-Cl inhibition. Previously we have
shown that MgADP protects against NBD-Cl inhibition of wild
type soluble F1 as well as membrane preparations of F1Fo; how-
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FIGURE 3. Inhibition of membrane-bound wild type and mutant ATP synthase by NBD-Cl. The membranes were preincubated for 60 min at room
temperature with varied concentration of NBD-Cl, and then aliquots added to
1 ml of assay buffer and ATPase activity were determined. The details are
given under “Materials and Methods.” F, wild type; E, ␣S347A; 䡺, ␣S347Q; ‚,
␣G351Q. Each data point represents an average of at least four experiments,
using two independent membrane preparations of each mutant. The results
agreed within ⫾10%.

ever, protection occurred only at high concentrations (EC50 ⫽
⬃4.5 mM MgADP). In this study the EC50 values were 5.1, 2.9,
3.0, and 4.0 mM for wild type, ␣S347Q, ␣S347A, and ␣G351Q,
respectively. We reason that high concentrations are required
to effectively keep the ␤E site occupied by MgADP in time
average and thus impede the access to NBD-Cl by sterically
obstructing the site (24 –30). This idea is consistent with the
conclusion of Orriss et al. (21), who provided evidence that
NBD-Cl reacts specifically in the ␤E catalytic site by x-ray crystallographic studies. We conclude that NBD-Cl is reacting in
␤E in the mutants and that the ATPase activities measured in
the mutants are referable to ATP synthase enzyme and not
caused by a contaminant.
MgPi protection against NBD-Cl reaction is presented in Fig.
6. It is evident that Pi protected well against NBD-Cl inhibition
of ATPase activity in wild type and ␣G351Q mutant but did
not protect at all against inactivation in ␣S347Q or ␣S347A
mutants.
Inhibition of ATPase Activity by Fluoroaluminate, Fluoroscandium, and Azide—We next examined the effects of transition state and ground state analogs. Fig. 7 (A and B) show
inhibition of wild type and mutant enzymes by MgADP-fluoroaluminate and MgADP-fluoroscandium, respectively. Wild
type and ␣G351Q were completely inhibited. ␣S347A showed
only ⬃25% inhibition. In contrast, the mutant ␣S347Q was
remarkably resistant to inhibition. Azide is also a potent inhibitor of ATPase in ATP synthase. Fig. 7C shows that although
wild type is strongly inhibited by azide, the mutants showed
VOLUME 284 • NUMBER 16 • APRIL 17, 2009
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FIGURE 4. Results of extra pulse of NBD-Cl in mutants and reversal of NBD-Cl effects by DTT. Left panel, membrane ATP synthase was inhibited with 150
M NBD-Cl for 60 min under conditions as described in Fig. 3. Then a further pulse of 200 M NBD-Cl was added, and incubation continued for 1 h before assay.
Right panel, membrane ATP synthase (Mbr) was incubated with or without 150 M NBD-Cl for 60 min under conditions as described for Fig. 3. The degree of
inhibition was assayed. In parallel samples, 4 mM DTT was then added, and incubation continued for further 60 min before assay. Each set of bars represents
wild type, ␣S347Q, ␣S347A, and ␣G351Q from left to right. The absolute residual ATPase activity values are as follows: wild type, 28, 0.36, 0.22; ␣S347Q, 0.20,
0.03, 0.02; ␣S347A, 2.18, 0.44, 0.39; and ␣G351Q, 0.25, 0.02, 0.01.

DISCUSSION

FIGURE 5. Protection against NBD-Cl reaction by MgADP. Wild type and
mutant membrane were preincubated for 1 h at room temperature with varied concentrations of MgADP as shown, then 150 M NBD-Cl was added, and
incubation continued at room temperature in the dark for 1 h. The aliquots
were then assayed for ATPase activity. F, wild type; E,␣S347A; 䡺, ␣S347Q; ‚,
␣G351Q. The results are the means of quadruplicate experiments which
agreed within ⫾10%.

varied resistance with ⬃70% inhibition in ␣G351Q and only
⬃20 –25% inhibition in ␣S347Q and ␣S347A mutants.
Inhibition of ATPase Activity by DCCD—Fig. 8 shows the
wild type and ␣S347Q, ␣S347A, and ␣G351Q mutant enzymes
inactivated by DCCD. Although wild type is completely inhibited by 200 M DCCD after16 h of incubation at room temperature, mutants show varied degrees of inhibition. ␣G351Q is
inhibited about 10%, ␣S347A is inhibited only ⬃30%, and
␣S347Q is not inhibited at all. In a similar series of experiments,
carried out with the same range of DCCD concentrations and
reaction conditions, but for only 2- or 5-h incubations, we
found that wild type still became fully inhibited, ␣G351Q and
␣S347Q both showed zero inhibition, and ␣S347A was inhibited maximally by 6% (2 h) and 15% (5 h).
APRIL 17, 2009 • VOLUME 284 • NUMBER 16

The goal of this study was to examine the functional role(s) of
residue ␣Ser-347 and ␣Gly-351 of E. coli ATP synthase. These
residues are part of the strongly conserved ␣-subunit VISITDG sequence. The VISIT-DG sequence residues are located in
close proximity to the ␣/␤ interface flanking the Pi-binding
pocket (Fig. 1B). X-ray crystal structures of the AlF3-inhibited
enzyme (22) as well as the AlF⫺
4 -inhibited enzyme (which also
contained SO2⫺
in a second catalytic site) (23) show that the
4
side chain of residue ␣Ser-347 is very close to these bound Pi
analogs (Fig. 1) and that ␣Gly-351 is also close. Pi binding is a
primary step in ATP synthesis by ATP synthase, thus exploring
the molecular basis of Pi binding is an important way to examine and understand the functional role of residues in the catalytic site.
Earlier studies established that mutagenesis combined with
the use of the Pi protection assay against NBD-Cl inhibition, as
well as the use of inhibitory analogs, enabled characterization of
functional role(s) of residues suspected to be involved in Pi
binding (24 –30). From analysis of six such catalytic site residues, we determined that four residues, namely, ␣Arg-376,
␤Arg-182, ␤Arg-246, and ␤Lys-155, are critical for Pi binding
and form a triangular subdomain within the catalytic site (24 –
30) (Fig. 1B). We also established that introduction of a negative
or positive charge in this location resulted in drastic modulation of Pi binding (25, 26, 30), indicating that negative charge
within the triangular subdomain was an important determinant
of Pi binding. Here we used the same approaches to study residues ␣Ser-347 and ␣Gly-351.
We introduced the mutations ␣S347Q, ␣S347A, and
␣G351Q, none of which affected assembly nor structural integrity of the membrane ATP synthase. Membranes showed similar content of F1-␣ and ␤ subunits as compared with wild type.
Both ␣S347Q or ␣G351Q mutations had severely inhibitory
effects on oxidative phosphorylation as judged by growth on
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FIGURE 6. Protection by Pi of ATPase activity in wild type (WT) and mutant membranes from inactivation by NBD-Cl. The membranes were preincubated
with MgPi at 0, 2.5, 5, or 10 mM concentration as shown, for 60 min at room temperature. Then NBD-Cl (150 M) was added, and aliquots were withdrawn for
assay at time intervals as shown. ATPase activity remaining is plotted against time of incubation with NBD-Cl. E, no Pi added; , 2.5 mM Pi; 䡺, 5 mM Pi; ‚, 10 mM
Pi. Each data point represents the average of four different experiments using two independent membrane preparations of each mutant.

FIGURE 7. Inhibition of membrane ATPase activity from mutant and wild type ATP synthase enzymes by fluoroaluminate, fluoroscandium, and azide.
The membranes were preincubated for 60 min at room temperature with 1 mM MgADP, 10 mM NaF, and the indicated concentrations of AlCl3 (A) or ScCl3 (B).
Then aliquots were added to 1 ml of assay buffer, and ATPase activity was determined. Sodium azide was added directly to the membranes and incubated for
30 min before assay (C), for details see “Materials and Methods.” F, wild type; E,␣S347A; 䡺, ␣S347Q; ‚, ␣G351Q. All of the data points are the means of at least
quadruplicate experiments. The variation was ⫾10% between different experiments.

succinate or limiting glucose medium, and both strongly inhibited ATPase activity. On the other hand the ␣S347A mutation
showed small residual oxidative phosphorylation and ATPase
activity (Table 1). The results with the ␣S347Q and ␣S347A
mutants showed that they abolished Pi binding (Fig. 6).
Although based on Table 1 data for ␣S347A mutant, it can be
argued that there could be a small amount of Pi binding in
cells but not significant enough to be measurable in the Pi
binding assay of membranes (Fig. 6). Fluoroaluminate and
fluoroscandium in combination with MgADP potently
inhibit wild type E. coli ATP synthase (24 –27, 30, 47, 48),
and both are believed to mimic the chemical transition state.
Transition state-like structures involving bound MgADPAlF⫺
4 complex have been seen in catalytic sites in ATP synthase by x-ray crystallography (23). It was evident that the
␣S347Q mutant strongly destabilized the transition state
(Fig. 7, A and B), because no inhibition by MgADP-fluoroaluminate or MgADP-fluoroscandium was apparent.
Clearly, therefore, residue ␣Ser-347 is involved directly and
to an important degree in catalysis and may be added as a
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fifth member of the group of Pi-binding residues that make
up the triangular Pi-binding pocket. ␣S347A mutant did
show some residual inhibition (⬃25%) with both MgADPfluoroaluminate and MgADP-fluoroscandium, which is in
agreement with the partial oxidative phosphorylation and
ATPase activity found in this mutant. In contrast, the
␣G351Q mutation did not prevent Pi binding (Fig. 6) and had
lesser effects in destabilizing the transition state as judged by
fluoroaluminate and fluoroscandium inhibition of ATPase
(Fig. 7, A and B). Its effects on catalysis are therefore more
indirect.
All of the mutations affected the degree of inhibition by
azide, with ␣S347Q reducing it substantially (by ⬃80%),
␣S347A reducing it substantially (⬃75%), and ␣G351Q reducing it by ⬃30% (Fig. 7C). A recent x-ray crystallography study
(49) showed that azide inhibits ATP synthase by forming a
tightly binding MgADP-azide complex in ␤DP catalytic sites,
which resembles that formed by MgADP-beryllium fluoride
and may therefore be considered an analog of the MgATP
ground state. In the MgADP-azide complex, azide occupies a
VOLUME 284 • NUMBER 16 • APRIL 17, 2009
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ABC signature sequence in P-glycoprotein (17). Considering
how Pi binding is affected, ␣Ser-347-OH lies 6.1 Å from atom
O2 in SO2⫺
(23) and 4.6 Å from F1 of AlF3 in the respective
4
catalytic sites (22). Thus some direct interaction may be operative. However, more important than the above may be the fact
that the Ser-OH lies 3.2 Å from the NH2 of ␤Arg-246 (in the
AlF⫺
4 site) and 3.0 and 4.1 Å, respectively from NH2 and NH1 of
␤Arg-246 in the AlF3-occupied site. ␤Arg-246 is strongly conserved and critical for Pi binding and transition state stabilization (24). Further, the carbonyl-O of ␣Ser-347 lies 3.2 Å from
NH2 of ␤Arg-182, another Pi-binding residue. The likely
H-bond interaction between ␣Ser-347 and ␤Arg-246 (and
␤Arg-182) suggests these residues act together to support Pi
binding and transition state stabilization. ␣Gly-351 is located at
2⫺
a distance of 7.7 Å from AlF⫺
4 and 8.7 Å from SO4 . A more
indirect role in catalysis is therefore indicated, likely predominantly structural in nature.
In summary, both ␣Ser-347 and ␣Gly-351 of the conserved
VISIT-DG sequence in ATP synthase ␣-subunit are required
for catalysis. ␣Ser-347 plays the more important role and is
required for Pi binding and transition state stabilization.
FIGURE 8. Inhibition of membrane ATPase activity from mutant and wild
type ATP synthase enzymes by DCCD. The membranes were preincubated
for 16 h at room temperature with varied concentrations of DCCD indicated in
the figure. Then 1 ml of ATPase assay buffer was added to determine the
activity. F, wild type; E, ␣S347A; 䡺, ␣S347Q; ‚, ␣G351Q. All of the data points
are means of at least quadruplicate experiments. The variation was ⫾10%
between different experiments.

position equivalent to that of the ␥-phosphate of MgATP. Thus
mutants also had effects on substrate binding by virtue of an
effect at the ␥-phosphate position.
DCCD inhibits wild type E. coli F1 by reacting with residue
␤Glu-192 (50) and/or cAsp-61 (51), with the latter predominating at lower DCCD concentration and/or shorter incubation
time. As expected, wild type ATP synthase was inhibited almost
100%. ␣S347Q mutant was not inhibited at all, ␣G351Q was
inhibited to ⬃10%, and mutant ␣S347A is inhibited ⬃30% (Fig.
8). Notably, at shorter incubation times, ␣S347A showed even
less inhibition (see “Results”). The data therefore indicate that
in the ␣S347A mutant, ATPase activity on F1 is only partly
coupled to proton translocation in Fo, which explains why
␣S347A mutant retains some growth on succinate and in limiting glucose (Table 1). It is interesting to note here that Pi
binding and release events have been shown to be directly
linked to rotation of the central stalk in single molecule experiments (52). Perturbation of the Pi-binding site might well be
anticipated to perturb the integrity of the link between Pi binding and rotation and be manifested as uncoupling. The overall
data on ␣S347A mutant strongly suggests that the Ser-OH
group is needed for transition state stabilization and Pi binding.
The availability of x-ray structures allows one to discuss in
detail the roles of residues ␣Ser-347 and ␣Gly-351. ␣Ser-347 is
positioned close to bound AlF⫺
4 in catalytic sites (Fig. 1B) (23).
The Ser-OH lies 5.0 Å from the F1 and F3 atoms in AlF⫺
4 and
thus may contribute to transition state stabilization by direct
interaction. It may be remarked that a similar conclusion was
reached regarding the Ser-OH of the highly conserved LSGGQ
APRIL 17, 2009 • VOLUME 284 • NUMBER 16
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